Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Do you modify the whole brain radiation dose if a patient has previously been treated with SRS for brain metastases?
Related Questions
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
Do you use a comprehensive volumetric, rather than numeric, cutoff in consideration of SRS vs WBRT for brain metastases?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
What normal tissue dose constraints do you use when delivering up to 3 cycles of the palliative quad shot regimen for gynecologic pelvic malignancies?
Do you have a 15 fraction constraint for the LADA?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
How would you manage a cardiac metastasis from Merkel cell carcinoma?
